[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346250-105":59,"doc-detail-346250-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hypoxia-promotes-progression-of-cervical-cancer-by-modulating-the-atxn3-enhanced-p53-stability-or-stat5-phosphorylation","Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation","","Hypoxia drives cervical cancer progression through subtype-specific molecular regulation involving ATXN3, with downstream effects on P53 stability and STAT5 phosphorylation. Clinical samples and cervical cancer cell lines (C33A, HeLa, SiHa) were profiled for ATXN3 expression following hypoxic stimulation and ATXN3 manipulation. ATXN3 showed subtype-dependent regulation: downregulated in HPV18+ adenocarcinoma and upregulated in HPV16+ squamous carcinoma. Functional assays linked ATXN3 loss or gain to changes in proliferation, migration, invasion, and corresponding shifts in P53 and p-STAT5 under HIF-1α control, supporting therapeutic potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hypoxia-promotes-progression-of-cervical-cancer-by-modulating-the-atxn3-enhanced-p53-stability-or-stat5-phosphorylation/346250/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hypoxia-promotes-progression-of-cervical-cancer-by-modulating-the-atxn3-enhanced-p53-stability-or-stat5-phosphorylation/346250.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does hypoxia influence cervical cancer progression in this study?","Question",{"text":112,"@type":113},"The study shows hypoxia promotes cervical cancer progression by regulating ATXN3 through HIF-1α-dependent mechanisms, leading to altered P53 stability and STAT5 phosphorylation across subtypes.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does ATXN3 play in different cervical cancer subtypes?",{"text":117,"@type":113},"ATXN3 is downregulated in HPV18+ adenocarcinoma but upregulated in HPV16+ squamous cell carcinoma, with ATXN3 suppressing malignant behaviors in C33A/HeLa while promoting them in SiHa.",{"name":119,"@type":110,"acceptedAnswer":120},"How are P53 and STAT5 affected by ATXN3 under hypoxic conditions?",{"text":121,"@type":113},"ATXN3 overexpression stabilizes P53 in C33A/HeLa and increases p-STAT5 in SiHa, while silencing ATXN3 produces inverse effects; hypoxic tissues show lower P53 and higher p-STAT5, particularly in HPV16+ SCC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},346250,1790146091,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","[www.nature.com/cddiscovery](www.nature.com/cddiscovery)  \nARTICLE OPEN   \nHypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation  \nRong Zhang 1,2,3,4,7, Shengjun Chai1,2,3,4,7, Fengjuan Zhang5,7, Jiaming Lai 1,2,3,4,6, Rui Wang 1,2,3,4, Guocai Xu1,2,3,4, Xiaoxia Fan1,2,3,4, Botong Li 1,2,3,4 and Chunmei Cai 1,2,3,4 ✉  \n© The Author(s) 2025  \n|  |  |  |\n| --- | --- | --- |\n|  | This study examines hypoxia’s role in regulating ATXN3 (ATXN3) across cervical cancer subtypes and its impact on tumor progression. We analyzed ATXN3 expression in clinical samples and cell lines (C33A, HeLa, SiHa), assessing proliferation/migration/ invasion after ATXN3 modulation. The study investigated whether ATXN3 is regulated by hypoxia through hypoxia-inducible factor 1α (HIF-1α) . Downstream mechanisms were explored using clinical samples and cell lines, comparing P53 and signal transducer and activator of transcription 5 (STAT5)/p-STAT5 levels between cancer tissues and adjacent non-cancerous tissues, and assessing changes following ATXN3 manipulation. ATXN3 was downregulated in human papillomavirus(HPV18+) cervical adenocarcinoma but upregulated in HPV16+ cervical squamous cell carcinoma. ATXN3 suppressed malignant behaviors in C33A and HeLa but promoted them in SiHa. HIF-1α expression was elevated in cancer tissues versus non-cancerous tissues, with hypoxic conditions differentially regulating ATXN3 via HIF-1α across cell lines. Cervical cancer tissues showed lower P53 and higher p-STAT5 (in HPV16+ squamous cell carcinoma) . ATXN3 overexpression stabilized P53 in C33A/HeLa and increased p-STAT5 in SiHa, with inverse effects upon silencing. The ﬁndings suggest that hypoxia promotes the progression of subtypes of cervical cancer by regulating ATXN3- |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| enhanced P53/p-STAT5 levels, which may provide a novel therapeutic strategy for clinical applications. |  |  |\n|  | Cell Death Discovery (2026)12:4; [https://doi.org/10.1038/s41420-025-02822-0](https://doi.org/10.1038/s41420-025-02822-0) |  |\n|  |  |  |\n\nINTRODUCTION  \nCervical cancer remains a major global health issue, causing approximately 661,000 new cases and 348,000 deaths annually, with a disproportionate impact in low-income regions where screening is limited [1, 2] . Although Human papillomavirus (HPV) vaccination has reduced high-grade cervical lesions by 31–51% in vaccinated groups, the absolute number of cases rose by 62.9% between 1990 and 2021 [3, 4] . Treatment is challenged by chemoresistance mediated by non-coding RNAs, limited access to costly targeted therapies such as bevacizumab, emerging resistance to newer drugs, and incomplete validation of immunotherapies [5–10] . Disease heterogeneity further complicates management: squamous cell carcinoma (SCC, 75%) and adenocarcinoma (AC, 20%) differ substantially, with AC showing consistently worse survival outcomes, while HPV- cases are rarerand more aggressive [11–15] . A deeper understanding of subtypespeciﬁc pathogenic mechanisms is essential to identify novel therapeutic targets and improve cervical cancer treatment.  \nDeubiquitinases, comprising over 100 members across seven subfamilies, play crucial yet context-dependent roles in cervical  \ncancer [16] . Some, such as ubiquitin-speciﬁc protease 26 (USP26) and cylindromatosis, function as tumor suppressors [17, 18], while others including USP13, OTU deubiquitinase 1, and USP18 promote oncogenesis [19–21] . Within the Josephindomain-containing Deubiquitinases, ataxin-3 (ATXN3) is the most well-characterized and exhibits tissue-speciﬁc duality: it acts as an oncogene in breast and prostate cancers but as a tumor suppressor in gastric and colorectal cancers[22–26] This functional ambiguity underscores the importance of investigating its role in cervical cancer subtypes. Mechanistically, ATXN3 ca","cbCaiaKerXkkePX9","https://ap.wps.com/l/cbCaiaKerXkkePX9","pdf",11188083,14,"English","# Introduction\n## Hypoxia, HPV-related heterogeneity, and treatment challenges\n## Deubiquitinases and ATXN3 dual roles\n## Hypoxia signaling via HIF-1α and proposed mechanisms","[{\"question\":\"How does hypoxia influence cervical cancer progression in this study?\",\"answer\":\"The study shows hypoxia promotes cervical cancer progression by regulating ATXN3 through HIF-1α-dependent mechanisms, leading to altered P53 stability and STAT5 phosphorylation across subtypes.\"},{\"question\":\"What role does ATXN3 play in different cervical cancer subtypes?\",\"answer\":\"ATXN3 is downregulated in HPV18+ adenocarcinoma but upregulated in HPV16+ squamous cell carcinoma, with ATXN3 suppressing malignant behaviors in C33A/HeLa while promoting them in SiHa.\"},{\"question\":\"How are P53 and STAT5 affected by ATXN3 under hypoxic conditions?\",\"answer\":\"ATXN3 overexpression stabilizes P53 in C33A/HeLa and increases p-STAT5 in SiHa, while silencing ATXN3 produces inverse effects; hypoxic tissues show lower P53 and higher p-STAT5, particularly in HPV16+ SCC.\"}]","Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation | PDF",1790060650,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/101fee20484c8f233744d59ef68c0ac3.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e48ac5f888bba913b0706a6858414fa9.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c72fbc2098433a34171b574db09ee533.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/607c96f7630c9eeecdf31f689706f897.webp",980,1301]